Bill Creating More Orphan Drugs Could Be Costly

As Congress pushes new legislation to speed medical innovations, a consumer watchdog group warns that one provision in the bill could cost US taxpayers, private insurers, and patients anywhere from $3.9 billion to $11.6 billion over a 10-year period.